Habil Khorakiwala on 3 things in the pipeline that can cause a re-rating for Wockhardt
Habil Khorakiwala says: “We have earlier signed an agreement on a profit-sharing basis for contract manufacturing with Serum Institute to make vaccines in our UK facility. This is a long 15-year agreement and we have earmarked capacity for 150 million doses for them. We are also in discussion with a global vaccine company for contract manufacturing opportunities.” Key Points
Economic TimesCentre revises COVID-19 guidelines; Warns over antibiotics usage sans bacterial infection
The AIIMS/ICMR-COVID-19 National Task Force met on January 5 to revise the clinical guidance protocol. It has also advised doctors not to use convalescent plasma therapy. Key Points
FinancialexpressIt is important to accelerate clinical trials to enable faster access to new drugs: Vikas Jain, Global Head, Life Sciences & Healthcare, TCS
Improving the public health infrastructure has been one of the most significant focus areas for India, Jain told Financial Express.com. Key Points
FinancialexpressGlobal pharma majors pitch for faster approval of innovative drugs in India but CDSCO remains cautious
Organisation of Pharmaceutical Producers of India seeks nod for drugs to be marketed at same time as US, Europe. But regulator rarely permits a drug launch without local clinical trials. Key Points
ThePrintIndia emerging as a hub for clinical trials, says Parexel
In the past, if they wanted to do clinical trials in 28 countries, India used to be 20th on the list. But, now, India started popping up among the top 5-10 countries (to do trials), said Sanjay Vyas, EVP, safety & logistics and country head. Key Points
Economic Times
XBB1.16 sub-variant most predominant in India: Study
According to a recent study, the clinical features and outcomes of XBB.1.16 infected patients are identical to those of other co-circulating Omicron lineage-infected individuals Key Points
Hindustan TimesAustralia is the first country to let patients with depression or PTSD be prescribed psychedelics
Australian physicians can prescribe doses of MDMA, also known as ecstasy, for PTSD. Psilocybin, the psychoactive ingredient in psychedelic mushrooms, can be given to people who have hard-to-treat depression. The country put the two drugs on the list of approved medicines by the Therapeutic Goods Administration. Key Points
India TodayNew research finds human gut-brain connection
Researchers at the Laureate Institute for Brain Research (LIBR) in Tulsa, Okla, have made significant advances in understanding the complex relationship between the gut and the brain. This relationship has long baffled scientists because it is challenging to gain access to the body's interior. The r Key Points
The Tribune IndiaBharat Biotech begins clinical trials of TB vaccine on adults in India
Bharat Biotech International Ltd has initiated clinical trials for the Tuberculosis vaccine Mtbvac on adults in India. Developed by the Spanish biopharmaceutical company Biofabri, Mtbvac is the first TB vaccine derived from a human source. The vaccine aims to be more effective and longer-lasting than the current BCG vaccine for newborns and to prevent TB in adults and adolescents, for whom there is currently no effective vaccine. The trials are a significant step, especially in a country like India where 28% of the world's TB cases occur. Key Points
Economic TimesFirst chikungunya vaccine, Ixchiq, approved by US Food and Drug Administration
The most commonly reported side effects were headache, fatigue, muscle pain, joint pain, fever, nausea and tenderness at the injection site, says the federal agency. Ixchiq, the first chikungunya vaccine, has been approved by the US Food and Drug Administration (FDA) for individuals 18 years of age and older who are at increased risk of exposure to mosquito-borne virus. Key Points
The Tribune India
First chikungunya vaccine, Ixchiq, approved by US Food and Drug Administration
The most commonly reported side effects were headache, fatigue, muscle pain, joint pain, fever, nausea and tenderness at the injection site, says the federal agency. Ixchiq, the first chikungunya vaccine, has been approved by the US Food and Drug Administration (FDA) for individuals 18 years of age and older who are at increased risk of exposure to mosquito-borne virus. Key Points
The Tribune IndiaHere's a long-awaited new FDA-Approved treatment for Alzheimer's - Read more
This could mark a new era for Alzheimer's treatment as the FDA grants full approval to a promising new drug called 'Lecanemab.' The drug is being sold by Eisai under the brand name 'Leqembi.' Key Points
Economic TimesDrug for pancreatic cancer shows promise against brain tumour in kids
New Delhi, August 2 A drug that was developed to treat pancreatic cancer has shown promise to treat medulloblastoma—the most common malignant brain tumour in children. In the study, published in the Journal of clinical Investigation, the drug triptolide, which... Key Points
The TribuneDassault Systemes' flagship platform sales slow, but targets confirmed
French software maker Dassault Systemes (DAST.PA) said revenue rose 5% in the second quarter, but shares fell to a four-month low after it flagged slower sales growth in its flagship platform and clinical data businesses. Key Points
ReutersEx-Pfizer employee charged with insider trading on COVID drug trial
A former employee of Pfizer Inc. was arrested on insider trading charges on Thursday for allegedly trading the drugmaker's stock before it announced positive results from clinical trials of its COVID antiviral drug Paxlovid, federal prosecutors said. Key Points
Reuters
clinical Gujarat Titans outclass Mumbai Indians by 55 runs; ‘little disappointing,’ says Rohit Sharma
This is a big win for GT. The winning margin of 55 runs have helped them to improve their IPL rankings. Now, they are at number 2 in the PL points table. Key Points
Financialexpress